Therapeutics Research Group, University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba 4102, QLD, Australia.
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia 4072, QLD, Australia.
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2214757120. doi: 10.1073/pnas.2214757120. Epub 2022 Dec 27.
Cell membrane-coated nanoparticles are emerging as a new type of promising nanomaterials for immune evasion and targeted delivery. An underlying premise is that the unique biological functions of natural cell membranes can be conferred on the inherent physiochemical properties of nanoparticles by coating them with a cell membrane. However, the extent to which the membrane protein properties are preserved on these nanoparticles and the consequent bio-nano interactions are largely unexplored. Here, we synthesized two mesenchymal stem cell (MSC) membrane-coated silica nanoparticles (MCSNs), which have similar sizes but distinctly different stiffness values (MPa and GPa). Unexpectedly, a much lower macrophage uptake, but much higher cancer cell uptake, was found with the soft MCSNs compared with the stiff MCSNs. Intriguingly, we discovered that the soft MCSNs enabled the forming of a more protein-rich membrane coating and that coating had a high content of the MSC chemokine CXCR4 and MSC surface marker CD90. This led to the soft MCSNs enhancing cancer cell uptake mediated by the CD90/integrin receptor-mediated pathway and CXCR4/SDF-1 pathways. These findings provide a major step forward in our fundamental understanding of how the combination of nanoparticle elasticity and membrane coating may be used to facilitate bio-nano interactions and pave the way forward in the development of more effective cancer nanomedicines.
细胞膜包覆纳米颗粒作为一种新型的有前途的纳米材料,具有免疫逃逸和靶向递送的作用。其潜在前提是通过将细胞膜包覆在纳米颗粒上,可以赋予纳米颗粒固有物理化学性质独特的生物功能。然而,这些纳米颗粒上的膜蛋白性质的保留程度以及由此产生的生物-纳米相互作用在很大程度上仍未得到探索。在这里,我们合成了两种间充质干细胞(MSC)细胞膜包覆的二氧化硅纳米颗粒(MCSN),它们具有相似的尺寸,但明显不同的硬度值(MPa 和 GPa)。出乎意料的是,与硬 MCSN 相比,软 MCSN 具有更低的巨噬细胞摄取率,但更高的癌细胞摄取率。有趣的是,我们发现软 MCSN 能够形成更富含蛋白质的膜涂层,并且该涂层具有高含量的 MSC 趋化因子 CXCR4 和 MSC 表面标记物 CD90。这导致软 MCSN 通过 CD90/整合素受体介导的途径和 CXCR4/SDF-1 途径增强了癌细胞的摄取。这些发现为我们深入了解纳米颗粒弹性和膜涂层的结合如何促进生物-纳米相互作用提供了重要的一步,并为开发更有效的癌症纳米药物铺平了道路。
Proc Natl Acad Sci U S A. 2023-1-3
Small Methods. 2023-6
Langmuir. 2021-10-12
J Drug Target. 2015
ACS Appl Mater Interfaces. 2018-6-26
ACS Nano. 2019-7-11
Acc Chem Res. 2019-5-6
Int J Mol Sci. 2021-9-3
Nanoscale Adv. 2025-8-26
J Nanobiotechnology. 2025-7-8
J Nanobiotechnology. 2025-5-30
Mater Today Bio. 2025-4-23
Bioact Mater. 2025-4-3
J Control Release. 2022-11
Proc Natl Acad Sci U S A. 2021-10-19
J Colloid Interface Sci. 2022-1-15
Acta Biomater. 2021-8
Front Cell Dev Biol. 2020-12-9